Metabolic syndrome and hemorrhagic stroke among symptomatic CCMs in the Mexican Hispanic Population
暂无分享,去创建一个
J. Zhang | M. Zuckerman | M. Kalas | M. Renteria | A. Dwivedi | J. Croft | O. Belkin | J. Aickareth | M. Hawwar | D. Jang
[1] A. Hazzou,et al. Stroke-related early seizures: clinical and neurophysiological study in a sample of Egyptian population , 2023, The Egyptian Journal of Neurology, Psychiatry and Neurosurgery.
[2] R. Mastrocola,et al. Heterozygous Loss of KRIT1 in Mice Affects Metabolic Functions of the Liver, Promoting Hepatic Oxidative and Glycative Stress , 2022, International journal of molecular sciences.
[3] A. Dwivedi,et al. Association of Exposure to Phthalate Metabolites With Sex Hormones, Obesity, and Metabolic Syndrome in US Women , 2022, JAMA network open.
[4] A. Dwivedi. How to write statistical analysis section in medical research , 2022, Journal of Investigative Medicine.
[5] Zhanghua Wu,et al. Five-year symptomatic hemorrhage risk of untreated brainstem cavernous malformations in a prospective cohort , 2022, Neurosurgical Review.
[6] Bixia Chen,et al. Cerebral cavernous malformations do not fall in the spectrum of PIK3CA-related overgrowth , 2022, Journal of Neurology, Neurosurgery, and Psychiatry.
[7] A. Nouet,et al. Somatic PIK3CA Mutations in Sporadic Cerebral Cavernous Malformations. , 2021, The New England journal of medicine.
[8] A. Perrelli,et al. Polymorphisms in genes related to oxidative stress and inflammation: Emerging links with the pathogenesis and severity of Cerebral Cavernous Malformation disease. , 2021, Free radical biology & medicine.
[9] J. Dekker,et al. Metabolic syndrome in patients with first-ever ischemic stroke: prevalence and association with coronary heart disease , 2021, Scientific Reports.
[10] M. Koepp,et al. Seizures and Epilepsy After Stroke: Epidemiology, Biomarkers and Management , 2021, Drugs & Aging.
[11] Bixia Chen,et al. Modifiable Cardiovascular Risk Factors in Patients With Sporadic Cerebral Cavernous Malformations , 2021, Stroke.
[12] P. S. Idiculla,et al. Cerebral Cavernous Malformations, Developmental Venous Anomaly, and Its Coexistence: A Review , 2020, European Neurology.
[13] Navkiran K. Shokar,et al. The association between metabolic syndrome and Hepatitis C virus infection in the United States , 2020, Cancer Causes & Control.
[14] A. Perrelli,et al. Dicarbonyl Stress and S-Glutathionylation in Cerebrovascular Diseases: A Focus on Cerebral Cavernous Malformations , 2020, Antioxidants.
[15] Rakesh Shukla,et al. Evidence-based statistical analysis and methods in biomedical research (SAMBR) checklists according to design features. , 2019, Cancer reports.
[16] J. Schmitt,et al. Metabolic Changes of Brain Developmental Venous Anomalies on 18F-FDG-PET. , 2019, Academic radiology.
[17] Jun Zhang,et al. Recent advances in cerebral cavernous malformation research , 2018, Vessel plus.
[18] Hualiang Lin,et al. Is Metabolic Syndrome Associated with the Risk of Recurrent Stroke: A Meta-Analysis of Cohort Studies. , 2017, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[19] G. Lanzino,et al. Prevalence of cerebral cavernous malformations associated with developmental venous anomalies increases with age , 2017, Child's Nervous System.
[20] A. Dwivedi,et al. Moderate and Severe Blood Pressure Elevation Associated with Stroke in the Mexican Hispanic Population , 2017, Health.
[21] N. Sarrafzadegan,et al. Metabolic Syndrome and the Risk of Ischemic Stroke. , 2017, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[22] S. Retta,et al. Oxidative stress and inflammation in cerebral cavernous malformation disease pathogenesis: Two sides of the same coin , 2016, The international journal of biochemistry & cell biology.
[23] M. Larvie,et al. Quantitative Analysis of Metabolic Abnormality Associated with Brain Developmental Venous Anomalies , 2016, Cureus.
[24] L. Morrison,et al. Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1 , 2016, Free radical biology & medicine.
[25] G. Lip,et al. Metabolic syndrome, atrial fibrillation, and stroke: Tackling an emerging epidemic. , 2015, Heart rhythm.
[26] M. Larvie,et al. Brain Metabolic Abnormalities Associated with Developmental Venous Anomalies , 2015, American Journal of Neuroradiology.
[27] I. Piña,et al. Status of Cardiovascular Disease and Stroke in Hispanics/Latinos in the United States: A Science Advisory From the American Heart Association , 2014, Circulation.
[28] Jun Zhang,et al. Metabolic syndrome associated with ischemic stroke among the Mexican Hispanic population in the El Paso/US-Mexico border region. , 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[29] E. Araki,et al. Prevalence of metabolic syndrome in stroke patients: a prospective multicenter study in Japan , 2014, Acute medicine & surgery.
[30] C. McCulloch,et al. Association of Cardiovascular Risk Factors with Disease Severity in Cerebral Cavernous Malformation Type 1 Subjects with the Common Hispanic Mutation , 2013, Cerebrovascular Diseases.
[31] C. Rosen,et al. Age and the Metabolic Syndrome as Risk Factors for Ischemic Stroke: Improving Preclinical Models of Ischemic Stroke , 2012, The Yale journal of biology and medicine.
[32] Kuo-Hsuan Chang,et al. Effect of pre-diabetes on future risk of stroke: meta-analysis , 2012, BMJ : British Medical Journal.
[33] Lawrence Joseph,et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. , 2010, Journal of the American College of Cardiology.
[34] L. Morrison,et al. Familial versus Sporadic Cavernous Malformations: Differences in Developmental Venous Anomaly Association and Lesion Phenotype , 2010, American Journal of Neuroradiology.
[35] D. Rigamonti,et al. Cavernous malformations: natural history, diagnosis and treatment , 2009, Nature Reviews Neurology.
[36] M. Inoue,et al. The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study , 2009, Hypertension Research.
[37] L. Morgenstern,et al. Stroke in minorities. , 2008, Neurologic clinics.
[38] K. Sheikh. Metabolic syndrome and stroke. , 2008, Stroke.
[39] K. Yamagishi,et al. Metabolic Syndrome and the Risk of Ischemic Heart Disease and Stroke among Middle-Aged Japanese , 2008, Hypertension Research.
[40] A. Unger,et al. Diabetes, hypertension, and dyslipidemia in Mexican Americans and non-Hispanic whites. , 2006, American journal of preventive medicine.
[41] P. Rothwell. Prevention of Stroke in Patients with Diabetes mellitus and the Metabolic Syndrome , 2005, Cerebrovascular Diseases.
[42] B. Crain,et al. Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations , 2001, Journal of neurology, neurosurgery, and psychiatry.
[43] H. Dietz,et al. Cloning of the murine Krit1 cDNA reveals novel mammalian 5' coding exons. , 2000, Genomics.
[44] Crone,et al. The natural history of cavernous malformations: a prospective study of 68 patients , 1999, Neurosurgery.
[45] R. Scott,et al. Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27. , 1998, Human molecular genetics.
[46] J. Weber,et al. Refined localization of the cerebral cavernous malformation gene (CCM1) to a 4-cM interval of chromosome 7q contained in a well-defined YAC contig. , 1995, Genome research.
[47] A. Elster,et al. An analysis of the natural history of cavernous angiomas. , 1991, Journal of neurosurgery.
[48] M. Hadley,et al. Cerebral cavernous malformations. Incidence and familial occurrence. , 1988, The New England journal of medicine.
[49] M. Hadley,et al. The MRI appearance of cavernous malformations (angiomas). , 1987, Journal of neurosurgery.
[50] J. Zabramski,et al. Developmental venous anomalies. , 2017, Handbook of clinical neurology.
[51] S. You,et al. Impact of metabolic syndrome components on incident stroke subtypes: a Chinese cohort study , 2014, Journal of Human Hypertension.
[52] B. Rilliet,et al. [131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies]. , 1989, Neuro-Chirurgie.